Veolity
MeVis Medical Solutions AGProduct specifications |
Information source:
Vendor
Last updated: Nov. 26, 2023 |
General | |
---|---|
Product name | Veolity |
Company | MeVis Medical Solutions AG |
Subspeciality | Chest |
Modality | CT |
Disease targeted | Lung Cancer |
Key-features | Nodule detection, segmentation and quantification, temporal registration and nodule comparison, report generation according to guidelines |
Suggested use | Before: flagging acute findings During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion |
Data characteristics | |
Population | Chest CTs on an asymptomatic population |
Input | 3D chest CT |
Input format | DICOM |
Output | CAD report, CAD overlay, radiology report |
Output format | DICOM SR, DICOM SC, DICOM GSPS, XML, PDF, TXT |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration CIS (Clinical Information System), Stand-alone third party application |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker) |
Trigger for analysis | Automatically, right after the image acquisition |
Processing time | |
Certification | |
CE
|
Certified,
Class IIa
, MDR
|
FDA
|
510(k) cleared, Class II |
Market presence | |
On market since | 03-2015 |
Distribution channels | Blackford |
Countries present (clinical, non-research use) | 25+ (including Europe, USA, Canada, Australia, Republik of Korea, Hong Kong, New Zealand) |
Paying clinical customers (institutes) | 500+ |
Research/test users (institutes) | Veolity is used in several clinical trials world-wide |
Pricing | |
Pricing model | |
Based on | |
Evidence | |
Peer reviewed papers on performance |
|
Non-peer reviewed papers on performance | |
Other relevant papers |